Sorbello AF - Search Results

1

Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S. Kim PW, et al. Among authors: sorbello af. Drug Saf. 2012 Jun 1;35(6):447-57. doi: 10.2165/11597460-000000000-00000. Drug Saf. 2012. PMID: 22612850 Review.

2

Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Jones SC, Sorbello A, Boucher RM. Jones SC, et al. Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000. Drug Saf. 2011. PMID: 21879778 Review.

3

Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients.

Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Fine AJ, et al. Clin Infect Dis. 2013 Sep;57(6):849-52. doi: 10.1093/cid/cit376. Epub 2013 May 31. Clin Infect Dis. 2013. PMID: 23728144

4

US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.

Jones SC, Budnitz DS, Sorbello A, Mehta H. Jones SC, et al. Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1099-106. doi: 10.1002/pds.3499. Epub 2013 Aug 20. Pharmacoepidemiol Drug Saf. 2013. PMID: 23963962 Free PMC article.

5

Progressive multifocal leukoencephalopathy after natalizumab discontinuation.

Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Fine AJ, et al. Ann Neurol. 2014 Jan;75(1):108-15. doi: 10.1002/ana.24051. Ann Neurol. 2014. PMID: 24242357

6

Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.

Winnenburg R, Sorbello A, Ripple A, Harpaz R, Tonning J, Szarfman A, Francis H, Bodenreider O. Winnenburg R, et al. J Biomed Inform. 2015 Oct;57:425-35. doi: 10.1016/j.jbi.2015.08.022. Epub 2015 Sep 2. J Biomed Inform. 2015. PMID: 26342964 Free PMC article.

7

Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing.

Sorbello A, Ripple A, Tonning J, Munoz M, Hasan R, Ly T, Francis H, Bodenreider O. Sorbello A, et al. Appl Clin Inform. 2017 Mar 22;8(1):291-305. doi: 10.4338/ACI-2016-11-RA-0188. Appl Clin Inform. 2017. PMID: 28326432 Free PMC article.

8

Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.

Sorbello A, Komo S, Valappil T, Nambiar S. Sorbello A, et al. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41. doi: 10.1086/653038. Clin Infect Dis. 2010. PMID: 20597669 Review.

9

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Sorbello A, Jones SC, Carter W, Struble K, Boucher R, Truffa M, Birnkrant D, Gada N, Camilli S, Chan I, Dallas S, Scales T, Kosko R, Thompson E, Goodman J, Francis H, Dal Pan G. Sorbello A, et al. Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5. Clin Infect Dis. 2012. PMID: 22491501

10

Reply: To PMID 24242357.

Fine AJ, Sorbello A, Kortepeter C. Fine AJ, et al. Ann Neurol. 2014 Mar;75(3):462-3. doi: 10.1002/ana.24108. Epub 2014 Mar 7. Ann Neurol. 2014. PMID: 24443375 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page